Abalparatide Injection (test formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Abalparatide Injection (test formulation), covering 2024-12-31 to 2024-12-31. Get the full timeline:
Most recent: Clinical Trial Update: A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects [Phase 1]